Lvdan Zhuo Pian (氯氮卓片)氯氮卓片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 济南永宁制药股份有限公司Chinese legal name: 济南永宁制药股份有限公司
主要成分Active Ingredients
- 氯氮卓Lvdan Zhuo
药物知识说明
氯氮卓是一种在国家药监局注册认定的药品。该药品含有氯氮卓-0b2cd385等成分。
该药品关联的活性成分包括：氯氮卓Lvdan Zhuo。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：济南永宁制药股份有限公司Chinese legal name: 济南永宁制药股份有限公司。
您可以探索含有相同成分的其他药品：氯氮卓-0b2cd385成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 氯氮卓片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 氯氮卓Lvdan Zhuo.
Manufacturers recorded for this product: 济南永宁制药股份有限公司Chinese legal name: 济南永宁制药股份有限公司.
Explore other medicines containing the same ingredient: 氯氮卓 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 氯氮卓片Recorded Chinese name: 氯氮卓片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 5mg*100片5 mg × 100 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 济南永宁制药股份有限公司Chinese legal name: 济南永宁制药股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H37022535
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H37022535
Manufacturer
Chinese legal name: 济南永宁制药股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
5 mg × 100 tablets
中文说明书原文Original Chinese source label
批准文号
国药准字H37022535
生产企业
济南永宁制药股份有限公司(国产)
适应症
本品用于。1.治疗焦虑性神经症，缓解焦虑，紧张，担心，不安与失眠等症状。2.治疗失眠症。3.治疗肌张力过高或肌肉僵直的疾病。4.与抗癫痫药合用控制癫痫发作。
用法用量
口服给药:|1.抗焦虑:一次5～10mg，一日2～3次。|2.治疗失眠:10～20mg睡前服用。|3.抗癫痫:一次10～20mg，一日3次。
不良反应
常见嗜睡，可见无力、头痛、晕眩、恶心、便秘等。偶见皮疹、中毒性肝损害、骨髓抑制。男性偶见阳痿。
禁忌
白细胞减少者、对本品过敏者。
注意事项
长期使用可产生耐受性与依赖性。肝、肾功能不全者慎用。应定期检查肝功能与白细胞计数。用药期间不宜驾驶车辆、操作机械或高空作业。长期用药后骤停可能引起惊厥等撤药反应。服药期间勿饮酒。
贮藏
遮光，密封保存。
规格
5mg*100片
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.